论文部分内容阅读
一、一般资料本组共收集肝硬化54例,肝功能均有不同程度的异常,且均经临床、生化检查及 B超证实的肝硬化患者.其中男45例,女9例,肝炎后肝硬化46例,洒精性肝硬化2例,原因不明者6例.54例随机抽样分为病情相似的实验组与对照组,前者29例,后者25例。二、治疗方法实验组:654—2,复方丹参注射液加入10%葡萄糖液500ml 中静脉点滴.654—2从每次10mg 起渐加至40mg(以不出现明显的心悸,尿潴留等副作用为
First, the general information of the group were collected in 54 cases of cirrhosis, liver function have varying degrees of abnormalities, and are clinically, biochemical tests and B-confirmed liver cirrhosis patients, including 45 males and 9 females, posthepatitic liver Forty-six cases were sclerosis, 2 cases were splenic cirrhosis, 6 cases were of unidentified origin.54 cases were randomly divided into experimental group and control group, with the former being 29 cases and the latter 25 cases. Second, the treatment of experimental group: 654-2, compound Danshen injection added 10% glucose solution 500ml intravenous drip .654-2 gradually increased from each 10mg to 40mg (to no obvious palpitations, urinary retention and other side effects